
Data from more than 800 US hospitals show that, despite improvements over the course of the COVID-19 pandemic, antibiotic prescribing for COVID-19 and other viral acute respiratory tract infections (ARTIs) remained higher than it should be, researchers reported this week in Open Forum Infectious Diseases.
The study, led by researchers from the University of Wisconsin-Madison School of Medicine and Public Health, analyzed antibiotic prescribing at 803 US hospitals, focusing specifically on antibiotic prescribed to patients admitted for COVID-19 from March 2020 through December 2023 and patients admitted for non-COVID viral ARTIs from January 2019 through December 2023. While the initial spike in antibiotic prescribing at US hospitals linked to the onset of the COVID-19 pandemic has been well-documented, the researchers wanted to assess the impact of the pandemic on antibiotic usage over time.
Continued need for antimicrobial, diagnostic stewardship
The study included 513,698 hospital encounters for COVID-19 and 106,932 for non-COVID viral ARTIs. In March 2020, antibiotics were prescribed for 82.7% of COVID-19 admissions. The rate of antibiotic prescribing for COVID fell to 30.5% in May 2022, with peaks of 50.8% in July 2021 during the Delta surge and 41.7% in July 2022 during the Omicron surge, then levels decreased to 33.8% in December 2023. For other viral ARTIs, the rate of antibiotic prescribing was 55.8% in January 2019, rose to 64.7% in July 2019, peaked at 68.1% in June 2020, declined to 40% in December 2022, then rose to 58.1% in April 2023.
Overall, 45.8% of COVID-19 admissions and 51.2% of viral ARTI admissions received at least one dose of antibiotic from March 2020 through December 2023.
"The perpetuation of high rates of potentially unnecessary antibiotic prescribing demonstrates a continued need for improved diagnostics, diagnostic stewardship, and antimicrobial stewardship programs to reduce antibiotic overprescribing for viral ARTIs," the study authors wrote.
"Future work should identify drivers of unnecessary antibiotic prescribing for viral ARTI admissions, implement strategies to promote resiliency in antimicrobial stewardship programs for future moments of operational upheaval, and examine the relationship between COVID-19 antibiotic prescribing patterns and antimicrobial resistance development in hospitals across the U.S."